相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induction of CD137 expression by viral genes reduces T cell costimulation
Meihui Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Hodgkin lymphoma cell lines: to separate the wheat from the chaff
Hans G. Drexler et al.
BIOLOGICAL CHEMISTRY (2018)
Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling
Makoto Nakashima et al.
BIOLOGY OF THE CELL (2018)
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
C. A. van der Weyden et al.
BLOOD CANCER JOURNAL (2017)
Targeting Immune System Alterations in Hodgkin Lymphoma
Natalie S. Grover et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
Robert Chen et al.
BLOOD (2016)
Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
Donatella Aldinucci et al.
CANCER LETTERS (2016)
CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth
Sakthi Rajendran et al.
ONCOIMMUNOLOGY (2016)
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Ingrid Glimelius et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
A novel human anti- interleukin-1∼ neutralizing monoclonal antibody showing in vivo efficacy
Angeline X. H. Goh et al.
MABS (2014)
Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression
Weng Tong Ho et al.
CANCER RESEARCH (2013)
Finding a needle in a haystack Activation-induced CD137 expression accurately identifies naturally occurring tumor-reactive T cells in cancer patients
Qunrui Ye et al.
ONCOIMMUNOLOGY (2013)
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Matthew W. Anderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Hodgkin lymphoma
Ralf Küppers et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
How I treat relapsed and refractory Hodgkin lymphoma
John Kuruvilla et al.
BLOOD (2011)
Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
Wolfgang Schaefer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2001)
分享论文
